OC
MTEM

Oppenheimer & Co’s Molecular Templates, Inc. MTEM Stock Holding History

Oppenheimer & Co’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,333
Closed -$9.6K – 1491
2023
Q2 		$9.6K Hold
1,333
– – ﹤0.01% 1409
2023
Q1 		$7.6K Hold
1,333
– – ﹤0.01% 1376
2022
Q4 		$6.56K Buy
1,333
+666
+100% +$5.51K ﹤0.01% 1346
2022
Q3 		$7K Hold
667
– – ﹤0.01% 1356
2022
Q2 		$9K Hold
667
– – ﹤0.01% 1397
2022
Q1 		$35K Buy
+667
New +$29.5K ﹤0.01% 1449

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Oppenheimer & Co's MTEM Position: Q3 2023 in Review

Oppenheimer & Co sold out of Molecular Templates, Inc. (MTEM) in Q3 2023, closing a stake of 1,333 shares — an estimated $9.6K sold.

Oppenheimer & Co first reported a position in MTEM in Q1 2022 and held it in 6 quarters. The position peaked at $35K in Q1 2022. 30 funds tracked by Wall St. Rank hold MTEM as of Q3 2023.

  • Oppenheimer & Co reported no remaining Molecular Templates, Inc. position as of Q3 2023 after selling out during the quarter.
  • Oppenheimer & Co sold 1,333 Molecular Templates, Inc. shares in Q3 2023, an estimated $9.6K.
  • Oppenheimer & Co first reported a position in Molecular Templates, Inc. in Q1 2022 and held it in 6 quarters.
  • Oppenheimer & Co's Molecular Templates, Inc. position peaked at $35K in Q1 2022.
  • 30 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2023.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.